The estimated Net Worth of Patrick A Mc Brayer is at least 29.2 千$ dollars as of 12 February 2018. Patrick Brayer owns over 1,000 units of Misonix Inc stock worth over 29,194$ and over the last 10 years Patrick sold MSON stock worth over 0$.
Patrick has made over 2 trades of the Misonix Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Patrick bought 1,000 units of MSON stock worth 10,540$ on 12 February 2018.
The largest trade Patrick's ever made was buying 1,000 units of Misonix Inc stock on 12 February 2018 worth over 10,540$. On average, Patrick trades about 183 units every 151 days since 2015. As of 12 February 2018 Patrick still owns at least 1,100 units of Misonix Inc stock.
You can see the complete history of Patrick Brayer stock trades at the bottom of the page.
Patrick's mailing address filed with the SEC is 1938 New Hwy, Farmingdale, NY 11735, USA.
Over the last 21 years, insiders at Misonix Inc have traded over 4,371,211$ worth of Misonix Inc stock and bought 1,536,334 units worth 6,620,934$ . The most active insiders traders include Stavros G. Vizirgianakis、Gary Gelman、Michael A Jr Mcmanus. On average, Misonix Inc executives and independent directors trade stock every 29 days with the average trade being worth of 378,885$. The most recent stock trade was executed by Sharon W Klugewicz on 20 May 2020, trading 825 units of MSON stock currently worth 10,032$.
Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.
Misonix Inc executives and other stock owners filed with the SEC include: